CYRX
Cryoport Inc
Price:  
6.98 
USD
Volume:  
1,109,194.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CYRX WACC - Weighted Average Cost of Capital

The WACC of Cryoport Inc (CYRX) is 7.4%.

The Cost of Equity of Cryoport Inc (CYRX) is 8.75%.
The Cost of Debt of Cryoport Inc (CYRX) is 5.50%.

Range Selected
Cost of equity 7.20% - 10.30% 8.75%
Tax rate 0.50% - 0.80% 0.65%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.9% - 9.0% 7.4%
WACC

CYRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.72 0.98
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.20% 10.30%
Tax rate 0.50% 0.80%
Debt/Equity ratio 0.68 0.68
Cost of debt 4.00% 7.00%
After-tax WACC 5.9% 9.0%
Selected WACC 7.4%

CYRX's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for CYRX:

cost_of_equity (8.75%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.72) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.